A company looking to buyout another company or to partner with a company looks at it's asset and intellectual property that can either benefit them.
In a buyout they can flush the employees so it's not a big consideration.
In a partnership it would be a consideration and would affect negotiations as to control of the partnered indication.
You are correct on the anti NP rhetoric , they want him gone in order to get Cytodyn for less. He is getting recognition for LL on an international scale and will keep getting the value increased. The prospects of a buyout or partnerships will keep increasing.
Is this a joke? BP wants NP gone so they can buy the company for less? NP leaving CYDY is worth $3-5 on the SP immediately. Having blind allegiance to NP is hurting shareholders and it needs to stop.
Market Data 
Markets 
AI
